Idelalisib
Generic name: Idelalisib
Brand names: Zydelig
Dosage form: oral tablet (100 mg; 150 mg)
Drug class:
PI3K inhibitors
Usage of Idelalisib
Idelalisib is used together with rituximab to treat chronic lymphocytic leukemia, and certain types of lymphoma.
Idelalisib is sometimes given after at least two other cancer treatments did not work or have stopped working.
Idelalisib was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis to treat lymphoma. In clinical studies, some people responded to idelalisib, but further studies are needed.
Idelalisib may also be used for purposes not listed in this medication guide.
Idelalisib side effects
Get emergency medical help if you have signs of an allergic Reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include: skin rash, fever, swollen glands, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes.
Idelalisib can cause serious harm to your liver, lungs, or intestines. You may have severe or life-threatening diarrhea, or a perforation (a hole or tear) in your intestines. Some of these conditions may lead to fatal complications.
Idelalisib may cause serious side effects. Call your doctor at once if you have:
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects of idelalisib may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Idelalisib
You may not be able to use idelalisib if you have ever had a serious skin reaction to any medicine.
Tell your doctor if you have ever had:
Idelalisib can harm an unborn baby if the mother or the father is using idelalisib.
Do not breastfeed while using this medicine, and for at least 1 month after your last dose.
Idelalisib is not approved for use by anyone younger than 18 years old.
Relate drugs
- Aliqopa
- Alpelisib
- Copanlisib
- Copiktra
- Duvelisib
- Idelalisib
- Joenja
- Piqray
- Piqray 200MG Daily Dose
- Piqray 250MG Daily Dose
- Piqray 300MG Daily Dose
- Vijoice
- Zydelig
How to use Idelalisib
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
You may take idelalisib with or without food.
Swallow the tablet whole and do not crush, chew, or break it.
You may have severe or life-threatening diarrhea while taking idelalisib. Tell your doctor at once if your daily bowel movements increase by 6 or more.
You may need frequent medical tests to be sure this medicine is not causing harmful effects. Your cancer treatments may be delayed based on the results.
Do not stop using idelalisib without your doctor's advice.
Store this medicine in the original container at room temperature, away from moisture and heat.
Warnings
Idelalisib can cause serious harm to your liver, lungs, or intestines. Some of these conditions may lead to fatal complications. Call your doctor right away if you have: upper stomach pain, easy bruising or bleeding, dark urine, yellowing of your skin or eyes, cough, wheezing, shortness of breath, fever, chills, worsening stomach pain, or vomiting.
You may have severe or life-threatening diarrhea while taking idelalisib. Tell your doctor at once if your daily bowel movements increase by 6 or more.
What other drugs will affect Idelalisib
Sometimes it is not safe to use certain medications at the SAMe time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Other drugs may affect idelalisib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions